ArticleIJU case reports2025
Percutaneous Transretropubic Needle Prostatic Biopsy Under US and CT Guidance.
Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: No previous instances of percutaneous transretropubic prostate biopsy have been documented. Case Presentation: A 74-year-old male patient with a permanent stoma, who had undergone colectomy for descending colon cancer two decades earlier, reported experiencing dysuria. A screening examination revealed an elevated prostate-specific antigen level of 120.24 ng/mL. Despite an intact rectum, the patient's anus was severely constricted or blocked, preventing both digital rectal examination and the insertion of a transrectal ultrasound probe. A transabdominal ultrasound-guided transretropubic prostate biopsy was conducted while monitoring the needle tip position using computed tomography. The subsequent pathological analysis confirmed prostatic adenocarcinoma. Conclusion: This case represents the first reported instance of a percutaneous transretropubic prostate biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.